ArticleJAC-antimicrobial resistance2023

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI).

Alexander C Branton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.